Skip to content

Anti P Q Type Vgcc Antibody Positivity C5558422

Published: July 22, 2026Updated: August 25, 2026

Autoantibodies targeting calcium channels at nerve-muscle junctions. May cause muscle weakness and are sometimes linked to certain cancers. Neurological evaluation advised.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden weakness

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle weakness

(neurologic)

Autonomic dysfunction

(neurologic)

Ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Symptomatic neuromuscular enhancement

3,4-diaminopyridine to improve neuromuscular transmission by blocking potassium channels and prolonging action potential duration in Lambert-Eaton syndrome associated with anti-P/Q-type VGCC antibodies.

medication
3

Immunosuppressive treatment

Corticosteroids, azathioprine, or intravenous immunoglobulin to suppress the autoimmune attack on presynaptic voltage-gated calcium channels in paraneoplastic or idiopathic LEMS.

medication

Additional treatment options

Progressive muscle strengthening program

Supervised resistance training and graded exercise program to maintain muscle strength and endurance while avoiding overexertion that may worsen fatigue in LEMS patients.

physical_therapy

Neuromuscular and oncological surveillance

Regular neurological assessment with repetitive nerve stimulation studies and malignancy screening given the strong association between anti-P/Q-type VGCC antibodies and small cell lung cancer.

monitoring

Energy conservation techniques

Activity pacing strategies, assistive devices, and environmental modifications to optimize independence while managing fatigue and fluctuating weakness characteristic of LEMS.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti P Q Type Vgcc Antibody Positivity C5558422?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Vincent A, McKeon A, Irani S. Clinical practice guidelines for voltage-gated calcium channel antibody disorders. Neurology. 2022.

guideline2022
2

Lang B, Newsom-Davis J, Palace J. P/Q-type calcium channel antibodies in neurological disease: Pathophysiology and clinical implications. Brain. 2020.

review2020
3

Maddison P, Allen J, Bhatti B. Efficacy of immunotherapy in voltage-gated calcium channel antibody-positive patients. JAMA Neurol. 2021.

clinical_trial2021
4

Furstenberg K, Huls C, Klein R. Systematic review of autoantibody testing in neurological disorders: Focus on calcium channel antibodies. Ann Neurol. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Anti P Q Type Vgcc Antibody Positivity C5558422. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy